- ICH GCP
- USA klinikai vizsgálatok nyilvántartása
- Klinikai vizsgálat NCT05244356
Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation (CONVINCE)
Effective Public Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation: A Randomized Controlled Experiment
A tanulmány áttekintése
Állapot
Körülmények
Beavatkozás / kezelés
Tanulmány típusa
Beiratkozás (Tényleges)
Fázis
- Nem alkalmazható
Kapcsolatok és helyek
Tanulmányi helyek
-
-
Selangor
-
Shah Alam, Selangor, Malaysia, 40170
- Institute for Clinical Research, National Institutes of Health, Malaysia
-
-
Részvételi kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
Egészséges önkénteseket fogad
Tanulmányozható nemek
Leírás
Inclusion Criteria:
- Willing and able to give informed consent for participation in the trial
- Malaysian nationality.
- Can understand either the English or Malay language.
- Aged 18 years or above
Exclusion Criteria:
- Received at least one COVID-19 vaccination dose
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Elsődleges cél: Egyéb
- Kiosztás: Véletlenszerűsített
- Beavatkozó modell: Párhuzamos hozzárendelés
- Maszkolás: Egyetlen
Fegyverek és beavatkozások
Résztvevő csoport / kar |
Beavatkozás / kezelés |
---|---|
Kísérleti: Descriptive Norm (70%)
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Kísérleti: Descriptive Norm
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Kísérleti: Healthcare worker (HCW) recommendation
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Kísérleti: Negative attribute framing
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Kísérleti: Positive attribute framing
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Kísérleti: Risky choice framing (Safety)
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Kísérleti: Risky choice framing (Side effects)
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Kísérleti: Control message
Control message containing only rally slogan: "It's safe and effective!"
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Kísérleti: Combination message: Descriptive Norm (70%) + Descriptive Norm
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Kísérleti: Combination message: Descriptive Norm (70%) + HCW recommendation
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Kísérleti: Combination message: Descriptive Norm (70%) + Negative attribute framing
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Kísérleti: Combination message: Descriptive Norm (70%) + Positive attribute framing
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Kísérleti: Combination message: Descriptive Norm (70%) + Risky choice framing (Safety)
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Kísérleti: Combination message: Descriptive Norm (70%) + Risky choice framing (Side effects)
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
---|---|---|
Change in intent to accept the COVID-19 vaccine amongst the Malaysian adult population.
Időkeret: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 4 point ordinal scale.
Scale ranges from '"Definitely no", "Not sure, but probably no", "Not sure, but probably yes"to Definitely yes".
|
Immediately before and after message exposure during questionnaire administration.
|
Change in intent to recommend the COVID-19 vaccine to healthy adults.
Időkeret: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately before and after message exposure during questionnaire administration.
|
Change in intent to recommend the COVID-19 vaccine to elderly.
Időkeret: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately before and after message exposure during questionnaire administration.
|
Change in intent to recommend the COVID-19 vaccine to people with existing health conditions.
Időkeret: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately before and after message exposure during questionnaire administration.
|
Intent to share message on social media platform.
Időkeret: Immediately after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately after message exposure during questionnaire administration.
|
Másodlagos eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
---|---|---|
Moderators of vaccination intent.
Időkeret: Immediately after message exposure during questionnaire administration.
|
Outcome measure assessed using a series of questions answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately after message exposure during questionnaire administration.
|
Reliability of various information sources about COVID-19.
Időkeret: Immediately after message exposure during questionnaire administration.
|
Outcome measure assessed using a questionnaire that list out various types of information sources and having participants to rate the reliability for each source using a 5 point ordinal scale.
Scale ranges from "Strongly not reliable", "Not reliable, "Not sure", "Reliable", and "Strongly reliable".
|
Immediately after message exposure during questionnaire administration.
|
Együttműködők és nyomozók
Szponzor
Együttműködők
Nyomozók
- Kutatásvezető: Yee Liang Hing, MSc., Clinical Research Centre, Malaysia
Publikációk és hasznos linkek
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Tényleges)
Elsődleges befejezés (Tényleges)
A tanulmány befejezése (Tényleges)
Tanulmányi regisztráció dátumai
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Tényleges)
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
Kulcsszavak
További vonatkozó MeSH feltételek
Egyéb vizsgálati azonosító számok
- NMRR-21-26-58107
Terv az egyéni résztvevői adatokhoz (IPD)
Tervezi megosztani az egyéni résztvevői adatokat (IPD)?
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .
Klinikai vizsgálatok a Koronavírus fertőzések
-
Rabin Medical CenterToborzásCentral-line Associated Blood Stream Infections (CLABSI)Izrael
-
Bactiguard ABKarolinska University HospitalBefejezveSebészet | Central Line Associated Blood Stream Infections (CLABSI)Svédország
-
Emory UniversityBefejezveCentral Line Associated Bloodstream Infections (CLABSI) | Csontvelő átültetésEgyesült Államok
-
Oneness Biotech Co., Ltd.BefejezveSúlyos akut légzőszervi szindróma okozta betegség Coronavirus 2 (rendellenesség)Egyesült Államok
-
TakedaBefejezveSúlyos akut légzőszervi szindróma által okozott fertőzések megelőzése Coronavirus-2 (SARS-CoV-2)Japán
-
Pomeranian Medical University SzczecinMég nincs toborzásOxigénhiány | Koronavírus fertőzés | ARDS a súlyos akut légzőszervi szindróma okozta betegség miatt Coronavirus 2Lengyelország
-
Brigham and Women's HospitalBefejezveKoronavírus | A Coronavirus Sars-hoz kapcsolódó, máshol besorolt betegség okozójaEgyesült Államok
-
University Hospital, Basel, SwitzerlandsciCORE University of Basel; Leonhard Med IT ETH Zurich; Swiss Institute of BioinformaticsToborzásSARS Coronavirus (SARS-CoV-2) fertőzésSvájc
-
Humanigen, Inc.Aktív, nem toborzóCoronavirus Disease 2019 (COVID-19) TüdőgyulladásEgyesült Államok, Brazília
-
Kanuni Sultan Suleyman Training and Research HospitalBefejezveCoronavirus Disease 2019 (COVID-19) TüdőgyulladásPulyka
Klinikai vizsgálatok a Health message exposure
-
Icahn School of Medicine at Mount SinaiNoom Inc.Aktív, nem toborzó
-
Florida State UniversityUniversity of North Carolina, Chapel Hill; University of GeorgiaJelentkezés meghívóvalSzív- és érrendszeri betegségek kockázatának csökkentéseEgyesült Államok
-
Icahn School of Medicine at Mount SinaiApple Inc.; Sage Bionetworks; Lifemap Solutions, IncBefejezve
-
Manan ShuklaBefejezveAsztma | Krónikus betegségEgyesült Államok
-
Massachusetts General HospitalLaguna Health, IncMegszűnt
-
Radicle ScienceAktív, nem toborzóHasi fájdalom | Emésztés | GI rendellenességekEgyesült Államok
-
Philips Electronics Nederland B.V. acting through...Medisch Spectrum TwenteToborzás
-
National Defense Medical Center, TaiwanBefejezveSzorongás | Akut szívinfarktus | Mobil egészség | Önhatékonyság | Határozatlan | Cardio-respiratory FitnessTajvan
-
University of MichiganBefejezveTelemedicinaEgyesült Államok